Prostate-specific membrane androgen PET/CT can help clinicians intensify or de-escalate care for men with prostate cancer who have biochemical recurrence following radical prostatectomy.A ...

A meta-analysis explores whether there’s a survival benefit to adding hormone therapy to postoperative radiation for patients with low PSA levels.

For men who have a detectable PSA of 0.5 ng/mL or less after radical prostatectomy and before salvage radiation therapy, hormone therapy may provide no overall survival or metastasis-free survival ...

ZOE Ball’s beloved dad Johnny Ball has revealed he believes he “doesn’t have long left” to live. Despite being given the ...

The therapeutic efficacy of radical prostatectomy and external beam radiation therapy in patients with histologic variants of prostate cancer. Perioperative outcomes from a randomized controlled trial ...

MiraDx, a molecular diagnostics company focused on genetic testing to personalize cancer treatment, today announced the U.S. commercial launch of PROSTOX™ Standard, a new, clinically validated genetic ...

EDAP management highlighted what it sees as a growing global opportunity for therapeutic ultrasound in urology, emphasizing the company’s Focal One robotic high-intensity focused ultrasound (HIFU) ...

FDA approves Pylarify TruVu, a new prostate cancer PET imaging agent designed to expand access and improve detection of recurrent or metastatic disease.

After a significant ruling from the Supreme Court of Appeal, prostate cancer patients in South Africa can continue to access the affordable generic drug Enzutrix, despite legal challenges from patent ...

A randomized phase 2 study of enhanced AR blockade with enzalutamide in high-risk patients with biochemical relapse undergoing salvage radiation: Final results from RTOG 3506 (STEEL). This is an ASCO ...

This side effect of hormonal therapy for prostate cancer has an equally negative effect on men as menopausal women.

An update from Telix Pharmaceuticals ( (AU:TLX) ) is now available.